Research facilities

Proteomics Facility

Connecting researchers with a highly specialised team and state-of-the-art proteomics platforms.

The WEHI Advanced Genomics Facility

Providing the very best support for WEHI researchers engaged in research using genomics approaches.

SIMOA HD-X service

Providing researchers with access to precise biomarker analysis using digital Simoa HD-X® technology.

Antibody Facility

Providing antibody services to academic researchers and commercial clients.

Advanced Histotechnology Facility

Histology aids medical research by unveiling intricate details of disease pathology, helping to guide personalised treatment strategies.

Olink proteomics platform

Olink affinity proteomics is a next-generation technology that quantifies thousands of biologically relevant proteins at low concentration in collections.

Group photo in a laboratory including Dr Sarah Diepstraten, Dr Eddie La Marca, Associate Professor Gemma Kelly, Dr Yin Yuan.

Meet the team who have found a potential new treatment for a common type of blood cancer.

The combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML).

Learn more

L-R: Dr Sarah Diepstraten, Dr Eddie La Marca, Associate Professor Gemma Kelly, Dr Yin Yuan

Latest discoveries and insights

Patients at heart for clinician-scientist

16 September 2024

High reward research: gene pathways that may cause autoimmune disease

12 September 2024

Outstanding breast cancer researcher honoured

09 September 2024

WEHI bioinformatician wins prestigious Eureka prize

05 September 2024

Two-in-one breakthrough: Cutting-edge immunotherapy could hold promise for incurable brain cancer

02 September 2024

Historic win for pioneering breast cancer researchers

28 August 2024

View all discoveries and insights

Research facilities